Mesentech is a pre-clinical platform company developing drug-conjugates targeted to bone. Our first product is a regenerative medicine product that targets mesenchymal stem-cells with a potent (sub nano-molar) prostaglandin mimetic that is released selectively in bone resulting in bone-regeneration. This drug can be used systemically to treat low-bone-density disorders or for local indications such as fracture-healing.
Location: Canada, British Columbia, Electoral Area A
Employees: 1-10
Founded date: 2016
Investors 5
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
| - | Boutique V... | boutiquevc... |
| 01.06.2021 | Creative D... | creativede... |
| - | Beresford ... | beresfordv... |
| - | E-Fund | e-fund.ca |
Mentions in press and media 1
| Date | Title | Description | Source |
| 25.11.2021 | Radar: Local exec shares 4 BC life sciences startups to watc... | As I’ve said before, even though I write about innovation every day, it’s not possible for me to kno... | vantechjou... |